In vitro evaluation of biodegradable ε-caprolactone-co-D,L-lactide/silica xerogel composites containing toremifene citrate

International Journal of Pharmaceutics

Volumn 181, Issue 2, 1999, Pages 181-191

  Ahola, M ^a   Rich, J ^b   Kortesuo, P ^c   Kiesvaara, J ^c   Seppala J ^b   Yli Urpo, A ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b AALTO UNIVERSITY   (Finland)

^c ORION CORPORATION   (Finland)

Author keywords

Caprolactone D,L lactide copolymer; Biodegradable polymers; Drug release; Silica xerogel; Toremifene citrate

Indexed keywords

COPOLYMER; DODECYL SULFATE SODIUM; LACTONE DERIVATIVE; POLYMER; SILICON DIOXIDE; TOREMIFENE;

ARTICLE; CONTROLLED RELEASE FORMULATION; DIFFERENTIAL SCANNING CALORIMETRY; DRUG RELEASE; GEL; GEL PERMEATION CHROMATOGRAPHY; IN VITRO STUDY; NUCLEAR MAGNETIC RESONANCE; POLYMERIZATION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS, HORMONAL; BIOCOMPATIBLE MATERIALS; BIODEGRADATION, ENVIRONMENTAL; DELAYED-ACTION PREPARATIONS; DRUG DELIVERY SYSTEMS; ESTROGEN ANTAGONISTS; GELS; POLYESTERS; SILICON DIOXIDE; TOREMIFENE;

EID: 0032919132     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00022-8     Document Type: Article

References (28)

1. Ahola, M., Kortesuo, P., Kangasniemi, I., Kiesvaara, J., Yli-Urpo, A., 1998. In vitro release behaviour of toremifene citrate from sol-gel processed sintered silica xerogels. Drug Dev. Ind. Pharm. (in press).
2. Bero M., Dobrzynski P., Kasperczyk J. Controlled release of steroids from lactide/ε-caprolactone copolymers. J. Control. Release. 48:1997;290.
3. Buntner B., Nowak M., Bero M., Dobrzynski P., Kasperczyk J. Controlled release of 17β-estradiol from D,L-lactide/ε-caprolactone copolymers. J. Bioact. Comp. Polym. 11:1996;110-120.
4. Den Dunnen W.F.A., Robinson P.H., van Wessel R., Pennings A.J., van Leeuwen M.B.M., Schakenraad J.M. Long-term evaluation of degradation and foreign-body reaction of subcutaneously implanted poly(D,L-lactide-ε-caprolactone). J. Biomed. Mater. Res. 36:1992;337-346.
5. Hench L.L., Andersson Ö. Bioactive glasses. Hench L.L., Wilson J. An introduction to bioceramics. 1993;41-62 World Scientific, Singapore.
6. Hiljanen-Vainio M.P., Karjalainen T., Seppälä J.V. Biodegradable lactone copolymers. I. Characterization and mechanical behaviour of ε-caprolactone and lactide copolymers. J. Appl. Polym. Sci. 59:1996;1281-1288.
7. Hiljanen-Vainio M.P., Orava P.A., Seppälä J.V. Properties of ε-caprolactone/DL-lactide (ε-CL/DL-LA) copolymers with a minor ε-CL content. J. Biomed. Mater. Res. 34:1997;39-46.
8. Kallio S., Kangas L., Blanco G., Johansson R., Karjalainen A., Perilä M., Piippo I., Sundqvist H., Södervall M., Toivola R. A new triphenylethylene compound, Fc-1157a. I. Hormonal effects. Cancer Chemother. Pharmacol. 17:1986;103-108.
9. Kasperczyk J., Bero M. The role of transesterification in the copolymerization of D,L-lactide and ε-caprolactone. Macromol. Chem. 194:1993;913-925.
10. Klein C.P.A.T., Li P., de Blieck-Hogervorst J.M.A., de Groot K. Effect of sintering temperature on silica gels and their bone bonding ability. Biomaterials. 16:1995;715-719.
11. Koch O.G., Koch-Dedic G.A. Silicomolybdänblau-Verfahren. Handbuch der Spurenanalyse. 1974;1105 Springer-Verlag, Berlin.
12. Kortesuo P., Ahola M., Karlsson S., Kangasniemi I., Kiesvaara J., Yli-Urpo A. Sol-gel-processed sintered silica xerogel as a carrier in controlled drug delivery. J. Biomed. Mater. Res. 44(2):1999;162-167.
13. Lapidus H., Lordi N.G. Drug release from compressed hydrophilic matrices. J. Pharm. Sci. 57:1968;1292-1301.
14. Lemmouchi Y., Schacht E. Preparation and in vitro evaluation of biodegradable poly(ε-caprolactone-co-D,L-lactide)(X-Y) devices containing trypanocidal drugs. J.Control. Release. 45:1997;227-233.
15. Lev O. Diagnostic applications of organically doped sol-gel porous glass. Analysis. 20:1992;543-553.
16. Li P., Ohtsuki C., Kokubo T., Nakanishi K., Soga N. Apatite formation induced by silica gel in a simulated body fluid. J. Am. Ceram. Soc. 75(8):1992;2094-2097.
17. Lordi N. Sustained release dosage forms. Lieberman L.H., Kanig J.L. Theory and Practice of Industrial Pharmacy. 1986;430-456 Lea and Febiger, Philadelphia.
18. Lowry K.J., Hamson K.R., Bear L., Peng Y.B., Calaluce R., Evans M.L., Anglen J.O., Allen W.C. Polycaprolactone/glass bioadsorbable implant in a rabbit humerus fracture model. J. Biomed. Mater. Res. 36:1997;536-541.
19. Nakanishi, K., 1991. Studies on morphology control of porous silica through polymer incorporated sol-gel processes, Ph.D. Thesis, Kyoto University, Japan.
20. Pitt C.G., Gratzel M.M., Jeffcoat A.R., Zweidinger R., Schindler A. Sustained drug delivery systems. II. Factors affecting release rates from poly(ε-caprolactone) and related biodegradable polyesters. J. Pharm. Sci. 68(12):1979;1534-1538.
21. Pitt C.G., Jeffcoat A.R., Zweidinger R.A., Schindler A. Sustained drug delivery systems. I. The permeability of poly(ε-caprolactone), poly(D,L-lactid acid), and their copolymers. J. Biomed. Mater. Res. 13:1979;497-507.
22. Sieminska L., Ferguson M., Zerda T.W., Couch E. Diffusion of steroids in porous sol-gel glass: application in slow drug delivery. J. Sol-Gel Sci. 8:1997;1105-1109.
23. Thombre A.G., Cardinal J.R. Sustained release dosage forms. Swarbrick J., Boylan J.C. Encyclopedia of Pharmaceutical Technology. Vol 2:1988;61-88 Marcel Dekker, New York.
24. Valavaara, R., 1990. Toremifene, a triphenyl antiestrogen, in the treatment of breast cancer, Ph.D. Thesis, University of Turku, Finland.
25. Vert M., Li S.M., Spenlehauerand G., Guerin P. Bioresorbability and biocompatibility of aliphatic polyesters. J. Mater. Sci. Mater. Med. 3:1992;432-446.
26. Wilson J., Pigott G.H., Schoen F.J., Hench L.L. Toxicology and biocompatibility of bioglasses. J. Biomed. Mater. Res. 15:1981;805-817.
27. Ye W.-P., Chien Y.W. Dual-controlled drug delivery across biodegradable copolymer. I. Delivery kinetics of levonorgestrel and estradiol through (caprolactide/lactide) block copolymer. Pharm. Dev. Technol. 1(1):1996;1-9.
28. Ye W.-P., Chien Y.W. Dual-controlled drug delivery across biodegradable copolymer. II. Delivery kinetics of levonorestrel and estradiol from (matrix/matrix) laminate drug delivery system. J.Control. Release. 41:1996;259-269.